Concepedia

David R. Blue

DR

12

Publications

736

Citations

12

H-Index

1990

Active since

Affiliations

Roche (United States)(Current)

La Roche College

Institute of Organic Chemistry

David R. Blue is an author at Roche (United States) specializing in medicine, molecular pharmacology, and pharmacology.

Top concepts

Publications per year

1990–2020

12

Publications

12

RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.

Anthony Ford, Nicolas F. Arredondo, David R. Blue et al. · Molecular Pharmacology · 1996 · 193 citations

Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild‐type and D79N α<sub>2A</sub>‐adrenoceptor transgenic mice

Q‐M Zhu, John Lesnick, Jeffrey R. Jasper et al. · British Journal of Pharmacology · 1999 · 95 citations · Full text

<i>In vitro</i>α<sub>1</sub>‐adrenoceptor pharmacology of Ro 70–0004 and RS‐100329, novel <i>α</i><sub>1A</sub>‐adrenoceptor selective antagonists

T.J. Williams, David R. Blue, Donald V. Daniels et al. · British Journal of Pharmacology · 1999 · 86 citations · Full text

, , +16

Functional evidence equating the pharmacologically‐defined α<sub>1A</sub>‐ and cloned α<sub>1C</sub>‐adrenoceptor: studies in the isolated perfused kidney of rat

David R. Blue, D W Bonhaus, Anthony Ford et al. · British Journal of Pharmacology · 1995 · 58 citations · Full text

α<sub>1L</sub>‐Adrenoceptor mediation of smooth muscle contraction in rabbit bladder neck: a model for lower urinary tract tissues of man

M. Shannon Kava, David R. Blue, Rachel L. Vimont et al. · British Journal of Pharmacology · 1998 · 56 citations · Full text

, , +24

Rows per page

1–5 of 12